Pharma/Med Device + Blogging

This isn't a new post from Jeremiah over at Web-Strategist.com, but I was going through some old materials that provides fodder for posts and thought I would throw it out there simply because it's good water cooler conversation.

First, the title is interesting in that he assumes that Pharma/Med Device ignore blogging. I would argue that nothing could be farther from the truth. It is likely a very frequent conversation in many organizations. Despite the likely perception at research organizations like Forrester, organizations generally have an idea of what they're doing. They hire firms like Forrester to validate what they would like to do; not entirely figure it out for them. I can be convinced otherwise, but that is a very arrogant approach.

Having been in the industry for 9 years I can say that the legal and regulatory risks are many as pointed out here and here previously and the positives simply don't outweigh the negatives at this moment in time.

The sheer structural change required to monitor and respond to comments and adverse effects is too much for most organizations. His view is surprisingly simplistic and doesn't value the complexity involved in moving large organizations. Change only occurs under a few premises--and is usually by force. Social media and blogging haven't quite forced the hand quite yet.
  • Digg
  • del.icio.us
  • StumbleUpon
  • Yahoo! Buzz
  • Technorati
  • Facebook
  • TwitThis
  • MySpace
  • LinkedIn
  • Live
  • Google
  • Reddit
  • Sphinn
  • Propeller
  • Slashdot
  • Netvibes

0 comments: